Covington Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $296K | Buy |
4,792
+55
| +1% | +$3.47K | 0.01% | 318 |
|
|
2022
Q2 | $293K | Sell |
4,737
-314
| -6% | -$19.4K | 0.01% | 323 |
|
|
2022
Q1 | $300K | Sell |
5,051
-14,309
| -74% | -$915K | 0.01% | 332 |
|
|
2021
Q4 | $1.41M | Buy |
19,360
+236
| +1% | +$16.3K | 0.05% | 205 |
|
|
2021
Q3 | $1.34M | Sell |
19,124
-100
| -0.5% | -$7.03K | 0.05% | 209 |
|
|
2021
Q2 | $1.32M | Sell |
19,224
-216
| -1% | -$14.4K | 0.05% | 209 |
|
|
2021
Q1 | $1.26M | Sell |
19,440
-109
| -0.6% | -$7.03K | 0.05% | 207 |
|
|
2020
Q4 | $1.14M | Sell |
19,549
-525
| -3% | -$31.7K | 0.05% | 201 |
|
|
2020
Q3 | $1.27M | Hold |
20,074
| – | – | 0.06% | 184 |
|
|
2020
Q2 | $1.54M | Sell |
20,074
-246
| -1% | -$18.9K | 0.09% | 167 |
|
|
2020
Q1 | $1.52M | Buy |
20,320
+600
| +3% | +$41.5K | 0.1% | 155 |
|
|
2019
Q4 | $1.28M | Sell |
19,720
-3,455
| -15% | -$225K | 0.07% | 180 |
|
|
2019
Q3 | $1.47M | Sell |
23,175
-845
| -4% | -$55.2K | 0.08% | 164 |
|
|
2019
Q2 | $1.62M | Sell |
24,020
-1,950
| -8% | -$128K | 0.1% | 159 |
|
|
2019
Q1 | $1.69M | Sell |
25,970
-3,269
| -11% | -$217K | 0.1% | 150 |
|
|
2018
Q4 | $1.83M | Buy |
29,239
+1,015
| +4% | +$70.9K | 0.13% | 137 |
|
|
2018
Q3 | $2.18M | Sell |
28,224
-2,150
| -7% | -$162K | 0.13% | 136 |
|
|
2018
Q2 | $2.15M | Sell |
30,374
-7,378
| -20% | -$521K | 0.14% | 131 |
|
|
2018
Q1 | $2.85M | Sell |
37,752
-2,805
| -7% | -$223K | 0.19% | 117 |
|
|
2017
Q4 | $2.91M | Sell |
40,557
-450
| -1% | -$34.2K | 0.18% | 117 |
|
|
2017
Q3 | $3.32M | Buy |
41,007
+79
| +0.2% | +$6.04K | 0.22% | 110 |
|
|
2017
Q2 | $2.9M | Sell |
40,928
-4,174
| -9% | -$278K | 0.23% | 107 |
|
|
2017
Q1 | $3.06M | Sell |
45,102
-13,972
| -24% | -$982K | 0.26% | 102 |
|
|
2016
Q4 | $4.23M | Sell |
59,074
-11,501
| -16% | -$855K | 0.37% | 83 |
|
|
2016
Q3 | $5.58M | Sell |
70,575
-20,053
| -22% | -$1.63M | 0.51% | 72 |
|
|
2016
Q2 | $7.56M | Sell |
90,628
-42,962
| -32% | -$3.81M | 0.7% | 54 |
|
|
2016
Q1 | $12.3M | Sell |
133,590
-1,491
| -1% | -$134K | 1.17% | 22 |
|
|
2015
Q4 | $13.7M | Sell |
135,081
-1,745
| -1% | -$182K | 1.33% | 16 |
|
|
2015
Q3 | $13.4M | Buy |
136,826
+2,833
| +2% | +$315K | 1.39% | 14 |
|
|
2015
Q2 | $15.7M | Sell |
133,993
-5,025
| -4% | -$549K | 1.4% | 14 |
|
|
2015
Q1 | $13.6M | Buy |
139,018
+5,943
| +4% | +$603K | 1.31% | 15 |
|
|
2014
Q4 | $12.5M | Buy |
133,075
+1,760
| +1% | +$182K | 1.11% | 21 |
|
|
2014
Q3 | $14M | Buy |
131,315
+205
| +0.2% | +$20.1K | 1.28% | 16 |
|
|
2014
Q2 | $11.5M | Buy |
131,110
+4,383
| +3% | +$341K | 1.05% | 28 |
|
|
2014
Q1 | $8.98M | Buy |
126,727
+24,325
| +24% | +$1.91M | 0.88% | 39 |
|
|
2013
Q4 | $7.69M | Sell |
102,402
-14,883
| -13% | -$1.04M | 0.78% | 42 |
|
|
2013
Q3 | $7.37M | Sell |
117,285
-450
| -0.4% | -$26.9K | 0.85% | 41 |
|
|
2013
Q2 | $6.04M | Buy |
+117,735
| New | +$6.14M | 0.74% | 48 |
|
Other funds holding GILD
Covington Capital Management's GILD Position: Q3 2022 in Review
Covington Capital Management increased its Gilead Sciences (GILD) stake by 1.2% in Q3 2022, buying an estimated $3.47K and bringing the position to 4,792 shares worth $296K. The position accounts for 0.01% of the portfolio, ranked #318.
Covington Capital Management first reported a position in GILD in Q2 2013 and has held it in 38 quarters since. The position peaked at $15.7M in Q2 2015. 1,603 funds tracked by Wall St. Rank hold GILD as of Q3 2022.
- Covington Capital Management held 4,792 shares of Gilead Sciences worth $296K as of Q3 2022.
- Covington Capital Management bought 55 Gilead Sciences shares in Q3 2022, an estimated $3.47K.
- Gilead Sciences made up 0.01% of Covington Capital Management's portfolio in Q3 2022, its #318 holding.
- Covington Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 38 quarters since.
- Covington Capital Management's Gilead Sciences position peaked at $15.7M in Q2 2015.
- 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.
Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.